EMA/PE/0000245628 - paediatric investigation plan

ivonescimab

Key facts

• Active substance:
  ivonescimab
• Therapeutic area:
  Neoplasms benign, malignant and unspecified (incl cysts and polyps)
• Decision number:
  EMA/PE/0000245628
• PIP number:
  EMA/PE/0000245628
• Pharmaceutical form(s):
  All pharmaceutical forms
• Condition(s) / indication(s):
  Treatment of head and neck epithelial malignant neoplasms
• Route(s) of administration:
  All routes of administration
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  12/06/2025
• Compliance check done:
  Nu

Decision

EMA/PE/0000245628 : EMA decision of 12 June 2025 on the granting of a product specific waiver for ivonescimab

Adopted Reference Number: EMADOC-1700519818-2187664